Stay updated with breaking news from Human Services Under Contract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi's SARS-CoV-2 spike protein (B.1.351 strain) vaccine, (VidPrevtyn Beta) is the first and only Beta variant protein-based COVID-19 booster approved in Great Britain and the European Union
Investegate announcements from Sanofi - Aventis Groupe, Press Release: Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved